Prelude Therapeutics Incorporated (PRLD)

Prelude Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	47.53	12.47	25.29	30.61	31.83	218.31
Short-Term Investments	7.43	121.14	207.64	171.12	259.41	-
Cash & Short-Term Investments	54.96	133.61	232.94	201.73	291.23	218.31
Cash Growth	-64.23%	-42.64%	15.47%	-30.73%	33.40%	1056.36%
Prepaid Expenses	3.37	2.28	2.65	2.65	3.88	2.5
Total Current Assets	58.33	135.9	235.59	204.38	295.12	220.81
Property, Plant & Equipment	33.08	35.47	37.74	6.7	5.64	2.48
Other Long-Term Assets	3.35	4.15	4.34	9.42	4.35	0.3
Total Assets	94.76	175.52	277.67	220.5	305.1	223.59
Accounts Payable	2.53	7.73	4.58	6.78	7.84	3.92
Accrued Expenses	12.93	14.44	14.82	12.57	9.53	7.04
Current Portion of Leases	2.73	2.7	1.48	1.83	1.74	-
Other Current Liabilities	-	0.77	0.95	0.52	0.09	0.42
Total Current Liabilities	18.19	25.64	21.83	21.7	19.2	11.38
Long-Term Leases	15.13	15.33	15.41	-	-	-
Other Long-Term Liabilities	2.9	3.09	3.34	3.36	-	0.03
Total Liabilities	36.22	44.06	40.58	25.06	19.2	11.41
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	725.13	714.98	693.25	531.68	505.72	319.61
Retained Earnings	-666.6	-583.56	-456.39	-334.56	-219.12	-107.43
Comprehensive Income & Other	0	0.04	0.22	-1.69	-0.71	-
Total Common Equity	58.53	131.46	237.09	195.44	285.9	212.18
Shareholders' Equity	58.53	131.46	237.09	195.44	285.9	212.18
Total Liabilities & Equity	94.76	175.52	277.67	220.5	305.1	223.59
Total Debt	17.85	18.03	16.89	1.83	1.74	-
Net Cash (Debt)	37.1	115.59	216.05	199.9	289.49	218.31
Net Cash Growth	-72.62%	-46.50%	8.08%	-30.95%	32.61%	1072.38%
Net Cash Per Share	0.49	1.52	3.58	4.22	6.29	17.49
Filing Date Shares Outstanding	62.87	75.99	75.73	47.71	47.02	45.37
Total Common Shares Outstanding	56.6	75.98	75.72	47.7	46.99	42.49
Working Capital	40.14	110.25	213.76	182.68	275.91	209.43
Book Value Per Share	1.03	1.73	3.13	4.10	6.08	4.99
Tangible Book Value	58.53	131.46	237.09	195.44	285.9	212.18
Tangible Book Value Per Share	1.03	1.73	3.13	4.10	6.08	4.99
Machinery	-	10.33	8.97	5.72	4.38	2.72
Construction In Progress	-	-	0.34	1.64	0.67	-
Leasehold Improvements	-	1.7	1.58	0.88	0.88	0.45

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q